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Abstract
Segmentation, the process of delineating tumor apart from healthy tissue, is
a vital part of both the clinical assessment and the quantitative analysis of
brain cancers. Here, we provide an open-source algorithm (MITKats), built on
the Medical Imaging Interaction Toolkit, to provide user-friendly and expedi-
ent tools for semi-automatic segmentation. To evaluate its performance against
competing algorithms, we applied MITKats to 38 high-grade glioma cases from
publicly available benchmarks. The similarity of the segmentations to expert-
delineated ground truths approached the discrepancies among different manual
raters, the theoretically maximal precision. The average time spent on each
segmentation was 5 minutes, making MITKats between 4 and 11 times faster
than competing semi-automatic algorithms, while retaining similar accuracy.
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1. Introduction
Glioblastoma (GBM) is the most common primary brain malignancy, and
the one with the most dismal prognosis (DeAngelis, 2001). Imaging, particularly
magnetic resonance imaging (MRI), is the standard for diagnosing and assess-
ing the disease (Mabray et al., 2015). The delineation of tumor volumes within
images, or segmentation, is important for guiding therapy (Dupont et al., 2016;
Bauer et al., 2013a), determining prognosis (Kickingereder et al., 2016; Cui et al.,
2015), and assessing response(Chow et al., 2014; Clarke et al., 1998). Related
quantitative spatial analyses have demonstrated utility in predicting molecular
subtypes (Yang et al., 2016) and survival (Czarnek et al., 2017; Mazurowski
et al., 2014; Zhang et al., 2014) of glioblastoma patients. Given the availability
of public imaging datasets such as The Cancer Imaging Archive (Clark et al.,
2013), there is a clear need for the development of efficient and accurate seg-
mentation utilities, which will allow for the systematic quantification of images
in association with clinical and molecular characteristics.
1.1. Related Work
Manual segmentation is typically performed with 2D tools to delineate edges
on each image slice. While manual segmentation is the gold standard (Porz
et al., 2014), it is too time-consuming for large analyses, sometimes taking up-
wards of an hour per image series (Kaus et al., 2001). Because of this, many
fully automatic and semi-automatic algorithms have been created to expedite
the segmentation process. Reviews of these methods can be found in Bauer et al.
(2013b) and Wang and Liu (2014). Benchmarks of fully automatic algorithms
have demonstrated encouraging accuracies (Menze et al., 2015), but acceptance
of these methods in the clinic is limited due to concerns about errors and trans-
parency (Gordillo et al., 2013). Semi-automatic algorithms draw a balance by
unifying the power of computer processing with the intuition of the human op-
erator. However, existing semi-automatic programs still need improvement with
regards to operator time (Fyllingen et al., 2016) and user-friendliness (Ramku-
mar et al., 2016).
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1.2. Contribution
To address these drawbacks, this work provides and validates an accessible
semi-automatic protocol for the fast segmentation of glioblastomas. Specific
goals included the creation of an intuitive computer-assisted segmentation util-
ity, addition of 3D editing tools for manual correction, and integration within a
user-friendly environment. These aims were implemented in the Medical Imag-
ing Interaction Toolkit (MITK) as an extension of its existing Segmentation
plugin (Wolf et al., 2005; Maleike et al., 2009). This modified software, MITK
with augmented tools for segmentation (MITKats), is also a free and open-
source program. By addressing the aforementioned goals with MITKats, we
expedite semi-automatic segmentation by introducing validated, easy-to-use 3D
tools.
2. Methods
2.1. Data sources
A total of 38 3D MRIs of brain tumors were obtained from two publicly
available datasets. 20 cases of high-grade gliomas (including glioblastomas and
anaplastic astrocytomas) were obtained from the Multimodal Brain Tumor Seg-
mentation Challenge (BRATS) 2012 (Menze et al., 2015), a notable accuracy
benchmark. Four modalities were available for the BRATS dataset: T1, T1
with contrast (T1c), T2, and T2 FLAIR, though MITKats only used T1c and
FLAIR images. The ground truths were derived from all four modalities and
designated into 3 regions:
• Active: The contrast-enhancing parts of the tumor, seen on T1c
• Core: The Active component plus non-enhancing features seen on T1,
including necrosis
• Whole: The hyper-intense region on T2 and FLAIR, corresponding to
edema
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18 cases of glioblastoma were obtained from a previously published study
performed at St. Olav’s University Hospital (Fyllingen et al., 2016). Only T1c
MRIs were used to create segmentations, which were generated in BrainVoyager
(Goebel et al., 2006), 3D Slicer (Egger et al., 2013), and ITK-SNAP (Yushkevich
et al., 2006). A single tumor region was labeled, comprising enhancing and
necrotic regions. Given that the authors did not observe non-enhancing tumor
regions, their definition of tumor was closest to that of the Core component
from BRATS. While no ground truths were designated in this dataset, each
segmentation was timed, serving as a speed benchmark.
Both datasets had originally been pre-processed, resulting in interpolation
of image resolutions to a 1mm isotropic voxel size. Images from BRATS had
been skull-stripped, while those from St. Olav’s had not.
2.2. Algorithmic Development
Two modifications were made to the MITK framework in order to expedite
the segmentation process in MITKats. First, the Threshold Components tool
was added, which expanded connected threshold segmentation to accept multi-
ple seed points (and thus separated regions). It also allowed for the manipula-
tion of seed points independently of the thresholds, as well as streamlining out
unnecessary user input. The second modification was adding in segmentation
capability to the Clipping Plane View, which was originally intended for volume
measurements only. Therefore, a segmentation could be graphically adjusted in
three dimensions through extraction of a clipped piece.
MITKats can be found here: https://github.com/RabadanLab/MITKats,
and is in the process of being merged onto the main branch of MITK.
2.3. Segmentation Protocol
Segmentations were performed in MITKats by A.X.C., a medical student
who had used similar software to segment 93 glioblastoma cases as part of a
previous project (Crawford et al.). Segmentation time, as measured by stop-
watch, was started after loading the original image(s) and stopped after opening
the save segmentation dialog, thus ignoring the time for file operations.
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Figure 1: Demonstration of a user-friendly semiautomatic segmentation protocol.
a) The Threshold Components tool allows the user to set an intensity threshold and multiple
seedpoints (yellow crosses). Regions within the threshold and connected to the seedpoints are
selected. b) The deformable clipping plane allows 3D correction of the segmentation, typically
useful for removing leaked regions. c) Original image, clipped image, and final morphological
operations such as Closing and Fill Holes smooth the enhancing segmentation into a Core
segmentation.
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2.3.1. Thresholding
A new segmentation label was created for the T1c image, and the Seg-
mentation plugin view is opened. Selecting the newly implemented Threshold
Components tool, seed point(s) were placed in enhancing region(s), and the
lower threshold adjusted until the apparent hyper-intensities were all included
(Fig. 1a). If the tumor was grossly non-enhancing, another label was created
where seed point(s) were placed in hypo-intense regions, and the upper threshold
adjusted.
2.3.2. Cropping
Regions of normal brain tissue that were erroneously included as part of the
Thresholding process were removed in two ways. Precise exclusion of regions was
done via the Clipping Plane tool, where up to 6 deformable 3D surfaces were
superimposed on the segmentation. This allowed the generalized separation
of erroneous regions from the tumor body (Fig. 1b), a new feature added in
MITKats. For gross corrections, the existing Image Cropping tool could be
used instead. A 3D rectangular bounding box was graphically defined and used
to mask and overwrite the original segmentation. Finally, if the true tumor
contained only one connected component, either of these methods could be
followed up with the Picking tool to exclude erroneous regions that were severed
from the tumor.
2.3.3. Smoothing and Filling
The segmentation was smoothed via the Closing tool, a part of the existing
set of Morphological Operations, typically with a radius of 2. This label was
saved as the Active component. For the Core volume, the non-enhancing label
could be joined to this component via the Union tool, if applicable. To include
areas of necrosis, the Closing and Fill Holes tools were used (both typically with
radius of 10), and this new label was saved as the Core component (Fig. 1c).
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2.3.4. Whole Tumor
For segmenting the Whole tumor component of the BRATS dataset, the
above protocol for obtaining the Core region was repeated for the FLAIR image.
2.4. Accuracy and Speed Analysis
The accuracy of MITKats segmentations was assessed by comparison to
the reference segmentations provided by BRATS and St. Olav’s datasets. In
BRATS, the references were ground truths fused from 4 expert manual annota-
tions. Each of the Whole, Core, and Active components were compared to their
reference counterparts via Dice score (Dice, 1945) as well as calculated tumor
volume. The mean inter-rater Dice scores from BRATS were used as controls.
This was because the fused ground truths were derived from the individual ex-
pert annotations, artificially bolstering the Dice score between any given expert
and the fused standard.
For comparing data in the St. Olav’s cohort, the MITKats segmentations
were assessed via Dice score and volume to all 12 reference segmentations (3
softwares × 2 raters × 2 repetitions). As a control, Dice scores were calculated
only for pairs of reference segmentations created by different raters. The time to
create the Core component of the MITKats segmentation was compared against
the times reported in the dataset.
3. Results
Aggregate Dice scores and volume estimates of MITKats segmentations with
respect to BRATS ground truths for each tumor region are shown in Table 1.
The Dice similarity of MITKats segmentations compared to the ground truth
was equivalent to inter-rater variability for the Whole and Active tumor regions,
but was worse for the Core region. Volume measurements averaged over all
regions were 94% of those estimated by the ground truth, with a mean fractional
error of 18%.
A comparison of estimated volumes for each case across both datasets is
shown in Figure 2, including a logarithmic Bland-Altman analysis. While the
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Tumor Compartment Whole Core Active
Dice Score (%)
MITKats v. BRATS 88±5 84±10 77±14
BRATS Inter-rater 88±2 93±3 74±13
Volume Ratio 0.96 1.06 0.81
Volume Relative Error 10% 25% 20%
Table 1: Segmentation accuracy approaches inter-rater agreement in the Brain
Tumor Segmentation Challenge. Twenty high-grade glioma cases were segmented using
MITKats and compared against ground truths from BRATS. Three regions (Whole, Core, and
Active) were segmented for each patient, and the mean Dice scores (± standard deviation)
are shown. The volumes of each region were also compared to the ground truth.
volumes segmented by MITKats were similar to reference segmentations, they
tended to be underestimated, particularly for the Active tumor region of the
BRATS dataset.
The Core component of the MITKats segmentation was pairwise compared
to segmentations performed by other softwares in the St. Olav dataset. The
average Dice scores of MITKats segmentations compared to each of the reference
segmentations was 0.88, compared against their inter-rater agreement of 0.94
(Figure 3a).
The time for segmentation is also compared to the St. Olav’s dataset in
Figure 3b. The speed of MITKats as compared to those reported was an average
of 4, 5, and 11 times faster than ITK-SNAP, 3D Slicer, and BrainVoyager,
respectively. The typical Core segmentation using MITKats was 4.2 ± 2.0
minutes on the St. Olav’s dataset and 4.0 ± 3.1 minutes on the BRATS dataset,
where uncertainties represent standard deviation.
4. Discussion and Conclusion
To our knowledge, this work is the first to validate the use of the MITK
environment for the segmentation of brain tumors. Our modification MITKats
provides fast and accurate segmentation, combining a semiautomatic tool with
8
Figure 2: Comparison of segmented volumes by tumor region. a) Volumes calculated
using MITKats are compared against their reference standards for each tumor component.
(St. Olav segmentations designated only a single Core-like component.) b) A logarithmic
Bland-Altman plot is shown for different regions of segmentations, comparing the ratio of
segmented volumes to the averages of the base 10 logarithms of tumor volume (in mL). There
is a tendency for MITKats to underestimate tumor volume at low sizes, particularly in the
Active tumor component.
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Figure 3: MITKats is faster than other segmentation softwares, while approaching
optimal accuracy. a) Eighteen glioblastoma cases were segmented using MITKats and
compared against the segmentations performed in Fyllingen et al. (2016). Points represent
the average Dice score when compared to all other segmentations performed by different raters.
Error bars represent standard deviation. b) The time required for segmenting via MITKats
is compared to those using BrainVoyager, 3DSlicer, and ITK-SNAP (mean of 2 trials each).
10
flexible 3D editing, all wrapped in a user-friendly GUI. Benchmarking its accu-
racy against BRATS, it achieved a performance equal to inter-rater variability
across Whole and Active tumor regions. The Core tumor region was somewhat
lacking, perhaps due to our protocol not using T1 images, thus having different
definitions for the component. Benchmarking its speed against the St. Olav’s
dataset, MITKats was over 4 times faster than its quickest competitor. While
its accuracy was somewhat lower than inter-rater variability, the reference seg-
mentations were also semi-automatically derived, and therefore not necessarily
the ground truth. Finally, MITK is an open source toolkit which encourages
the free use and continued development of this software.
The scope of this work has some limitations with the protocol and datasets
used. This pipeline works best for T1c and FLAIR imagery, because T1 without
contrast has limited enhancement, and T2 enhancements are often the same
intensity as cerebrospinal fluid. We hope to provide implementation for other
modalities in the future as well as simultaneous multimodal analysis, which may
benefit the accuracy of segmentations (Dupont et al., 2016). Providing support
for perfusion and diffusion weighted images may also be particularly important
for response assessment (Huang et al., 2015).
One note is that the BRATS dataset contained not just glioblastomas but
also anaplastic astrocytomas, which are intermediates between GBMs and lower
grade gliomas (LGGs). Given the satisfactory accuracy of segmenting this mixed
dataset, this provides encouragement that MITKats could be extended to LGGs,
which are typically harder to segment (Akkus et al., 2015). Eventual implemen-
tation and validation for LGGs and tumors outside the brain would be use-
ful. Another point about the BRATS dataset is that the images were already
skull-stripped, making the segmentation process somewhat easier. Integrating
skull-stripping into our pipeline would be helpful for the user.
It is our belief that speed is not sufficiently emphasized in the current bench-
marking of segmentation algorithms. While many studies report average seg-
mentation times, the variability among different cases can be large. Within
the datasets examined in this work, the fastest segmentation took less than a
11
minute, while the slowest took almost 11 minutes. Therefore, the individual
listing of segmentation times is helpful for the direct comparison of algorithm
speeds. We encourage future investigators to record both raw segmentations
and operator time for each case to further advance this field.
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